Melanoma blood test using a new device (Cytophone)
Part of Cancer, Skin clinical trials.
This trial tests a new, non-invasive device called a liquid biopsy that looks for melanoma cells in your blood. It may help find cancer earlier without needing a needle biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with melanoma (a type of skin cancer).
- You must be able to sit still for up to one hour.
- You cannot have serious heart, liver, brain, or other major health problems that could make the study unsafe.
- You cannot have a severe or ongoing infection.
- If you are a woman who could become pregnant, you must be using effective birth control and not be pregnant or planning to become pregnant.
- You cannot have a history of hard-to-treat constipation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a special PET scan (FDG PET/CT) and a blood test that measures ctDNA (cancer DNA in the blood) can help predict how well immune checkpoint inhibitors work in people with advanced melanoma. If you are planning to get treatment with immunotherapy drugs like ipilimumab, nivolumab, or pembrolizumab, you may be able to join.
This trial is testing a simple blood test (liquid biopsy) to track how well melanoma responds to immunotherapy. It might help doctors decide if treatment is working or needs to be changed.
This trial tests a way to detect circulating melanoma cells (melanoma cells moving in the blood) in real time. If you have melanoma, you may be asked to take part in a session where the team measures your blood during the procedure.
This trial studies whether certain gene patterns and a blood test can help predict how melanoma might behave. It is for people with a thicker melanoma (greater than 2 mm) that has not spread to lymph nodes or other parts of the body, and who are planning to have a sentinel lymph node biopsy.
This study looks at serial (repeated) tumour biopsies and blood samples in people with advanced melanoma. The goal is to understand biomarkers and disease changes over time, which may help improve future treatment decisions.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.